Hologic Displays Automated Solutions And Expansive Diagnostic Menu to Help Labs Grow at AACC 2021
By LabMedica International staff writers Posted on 29 Sep 2021 |
Hologic, Inc. (Marlborough, MA, USA) displayed its automated solutions and expansive diagnostic menu that are designed to help labs grow at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo.
The annual event held in Atlanta on September 26-30 by the American Association for Clinical Chemistry (AACC) showcased the cutting edge science and technology shaping the future of laboratory medicine. Hologic demonstrated its range of Panther instrumentation and Aptima and Panther Fusion assays alongside its new ThinPrep Genesis Processor at the event.
Hologic demonstrated its Panther Scalable Solutions that allow labs to expand their testing menu while adding on flexibility, capacity and walkaway time. The Panther system serves as the foundation of Hologic’s automation with the option to add on the Panther Fusion module, Panther Plus, Panther Link and Panther Trax. Panther Scalable Solutions provide an economical and scalable path to lab’s growth today and into the future. Also on display at AACC 2021 was Hologic’s broad menu of Aptima and Panther Fusion assays to run on scalable automation that can help guide patient care and enable early detection.
In addition, Hologic highlighted its new ThinPrep Genesis Processor which offers automated chain of custody, streamlined cytology processing, and hands-free sample aliquoting in a single instrument to promote confidence in results while optimizing lab performance. The ThinPrep Genesis Processor is an intuitive, versatile, and scalable solution for laboratories of all volumes. The best-in-class system helps cytology labs automate their processes – decreasing the need for hands-on labor and increasing laboratory efficiencies.
Related Links:
Hologic, Inc.
Latest Molecular Diagnostics News
- Blood Proteins Could Warn of Cancer Seven Years before Diagnosis
- New DNA Origami Technique to Advance Disease Diagnosis
- Ultrasound-Aided Blood Testing Detects Cancer Biomarkers from Cells
- New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results
- New Synthetic Biomarker Technology Differentiates Between Prior Zika and Dengue Infections
- Novel Biomarkers to Improve Diagnosis of Renal Cell Carcinoma Subtypes
- RNA-Powered Molecular Test to Help Combat Early-Age Onset Colorectal Cancer
- Advanced Blood Test to Spot Alzheimer's Before Progression to Dementia
- Multi-Omic Noninvasive Urine-Based DNA Test to Improve Bladder Cancer Detection
- First of Its Kind NGS Assay for Precise Detection of BCR::ABL1 Fusion Gene to Enable Personalized Leukemia Treatment
- Urine Test to Revolutionize Lyme Disease Testing
- Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
- New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
- Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis
- Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans